A new medication targets peripheral nerves with a focused approach, differing from opioids that act on the central nervous system. While it shows some effectiveness compared to a placebo, it hasn't been directly compared to opioids, leaving questions about its potential as a substitute. The conversation highlights the complexity of pain pathways and the importance of identifying the source of pain for effective treatment.
